搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
arwr
/
财务摘要
Arrowhead Pharmaceuticals Inc
ARWR
添加自选
73.080
USD
-7.590
-9.41%
交易中 09/15, 14:21(美东)
10.31B
总市值
亏损
市盈率 TTM
异动资讯:
Arrowhead Pharmaceuticals Inc(ARWR)股票9月15日盘中下跌8.93%:真相来了
Arrowhead Pharmaceuticals Inc
73.080
-7.590
-9.41%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
ARWR 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Arrowhead Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
10.31B
股息TTM
0.00
市盈率 TTM
-32.19
每股收益TTM
-2.27
营业收入
829.45M
净利润
-1.63M
净资产收益率
-46.39%
总资产收益率
-14.15%
Arrowhead Pharmaceuticals Inc 财报日历
最新发布
8月 4, 2026
每股收益 / 预测值
-1.36
/-1.32
营业收入 / 预测值
75.25M
/54.29M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
财务指标
每股收益
-7.51%
-1.36
-133.55%
-0.93
116.22%
0.22
87.44%
-0.17
8.35%
-1.26
373.31%
2.78
-12.08%
-1.39
-34.05%
-1.37
-42.94%
-1.38
-322.91%
-1.02
-217.39%
-1.24
--
-1.02
--
-0.96
--
0.46
--
-0.39
--
-1.67
--
--
--
--
--
--
--
--
营业收入
171.02%
75.25M
-86.41%
73.74M
10461.32%
264.03M
--
256.47M
--
27.77M
--
542.71M
-29.60%
2.50M
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-94.32%
3.55M
-49.02%
16.10M
-51.18%
15.82M
-3.65%
146.27M
127.95%
62.55M
-17.52%
31.57M
-29.37%
32.41M
362.66%
151.81M
28.80%
27.44M
401.56%
38.28M
净利润
-10.86%
-194.28M
-135.83%
-132.73M
117.80%
30.81M
86.07%
-23.75M
-2.60%
-175.24M
395.65%
370.44M
-30.27%
-173.09M
-55.49%
-170.54M
-65.91%
-170.79M
-357.42%
-125.30M
-221.51%
-132.86M
-28.26%
-109.68M
-42.89%
-102.95M
9.71%
48.67M
34.27%
-41.33M
-34.93%
-85.51M
-140.76%
-72.05M
265.43%
44.37M
-203.26%
-62.87M
-30.85%
-63.37M
利润率
63.05%
-237.75%
-375.25%
-186.57%
100.15%
10.70%
--
6.29%
--
-643.40%
--
67.78%
-83.84%
-7008.72%
--
--
--
--
--
--
-5602.96%
-3812.33%
--
-689.66%
--
-657.98%
--
32.60%
--
-66.85%
--
-72.56%
--
--
--
--
--
--
--
--
毛利率
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
--
100.00%
--
100.00%
--
100.00%
0.00%
100.00%
--
--
--
--
--
--
0.00%
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
--
--
--
--
--
--
--
资产负债率
36.77%
59.50%
220.46%
55.79%
-10.77%
36.04%
30.22%
44.92%
--
43.50%
--
17.41%
--
40.39%
--
34.50%
--
--
--
--
--
--
--
--
--
33.05%
--
--
--
--
--
--
--
--
--
--
--
--
--
--
利润表
营业收入
171.02%
75.25M
-86.41%
73.74M
10461.32%
264.03M
--
256.47M
--
27.77M
--
542.71M
-29.60%
2.50M
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-94.32%
3.55M
-49.02%
16.10M
-51.18%
15.82M
-3.65%
146.27M
127.95%
62.55M
-17.52%
31.57M
-29.37%
32.41M
362.66%
151.81M
28.80%
27.44M
401.56%
38.28M
营业利润
-2.74%
-170.09M
-137.06%
-141.26M
125.28%
40.81M
127.19%
44.11M
6.01%
-165.55M
402.08%
381.20M
-18.21%
-161.41M
-49.73%
-162.20M
-71.51%
-176.14M
-362.00%
-126.19M
-224.07%
-136.54M
-29.23%
-108.33M
-40.86%
-102.70M
15.91%
48.16M
33.46%
-42.13M
-29.20%
-83.83M
-128.78%
-72.91M
247.18%
41.55M
-163.25%
-63.32M
-29.46%
-64.88M
净利润
-10.86%
-194.28M
-135.83%
-132.73M
117.80%
30.81M
86.07%
-23.75M
-2.60%
-175.24M
395.65%
370.44M
-30.27%
-173.09M
-55.49%
-170.54M
-65.91%
-170.79M
-357.42%
-125.30M
-221.51%
-132.86M
-28.26%
-109.68M
-42.89%
-102.95M
9.71%
48.67M
34.27%
-41.33M
-34.93%
-85.51M
-140.76%
-72.05M
265.43%
44.37M
-203.26%
-62.87M
-30.85%
-63.37M
资产负债表
流动资产
76.51%
1.67B
62.06%
1.84B
105.84%
1.17B
36.69%
950.64M
110.40%
946.92M
109.59%
1.14B
139.82%
570.54M
65.78%
695.47M
-4.28%
450.06M
-5.77%
541.65M
-58.63%
237.90M
3.51%
419.52M
8.74%
470.17M
37.64%
574.81M
69.98%
575.00M
5.38%
405.30M
-17.79%
432.39M
-28.82%
417.63M
4.50%
338.28M
19.30%
384.60M
流动负债总额
45.66%
283.35M
33.86%
295.22M
270.56%
347.43M
89.48%
195.49M
101.14%
194.53M
238.38%
220.54M
47.13%
93.76M
-2.17%
103.17M
37.72%
96.71M
-25.22%
65.17M
-47.77%
63.72M
-24.05%
105.46M
-45.23%
70.23M
-37.24%
87.15M
-10.96%
122.01M
-5.25%
138.85M
-34.40%
128.21M
-16.95%
138.86M
446.07%
137.03M
260.20%
146.54M
总资产
52.98%
2.11B
44.15%
2.27B
58.25%
1.60B
21.54%
1.39B
56.22%
1.38B
64.74%
1.57B
61.86%
1.01B
48.89%
1.14B
11.05%
883.76M
7.16%
955.15M
-29.75%
626.29M
10.64%
765.55M
5.86%
795.86M
26.68%
891.31M
39.61%
891.49M
-2.56%
691.94M
2.29%
751.78M
-7.03%
703.58M
27.90%
638.54M
35.91%
710.15M
总负债
91.21%
1.65B
87.72%
1.67B
8.76%
1.04B
-7.05%
881.88M
58.01%
860.81M
93.43%
889.27M
111.59%
957.62M
98.32%
948.74M
31.63%
544.78M
7.87%
459.75M
-8.59%
452.57M
74.85%
478.39M
49.09%
413.87M
69.59%
426.20M
86.15%
495.12M
-9.20%
273.60M
-6.86%
277.61M
-19.26%
251.31M
493.98%
265.98M
396.22%
301.33M
总权益
-10.34%
466.04M
-12.47%
598.92M
903.47%
562.70M
163.48%
503.42M
53.35%
519.81M
38.11%
684.23M
-67.72%
56.08M
-33.47%
191.06M
-11.26%
338.97M
6.51%
495.40M
-56.17%
173.71M
-31.36%
287.16M
-19.44%
381.99M
2.84%
465.11M
6.39%
396.37M
2.33%
418.34M
8.53%
474.18M
1.51%
452.27M
-18.02%
372.56M
-11.47%
408.82M
现金流量表
经营净额
-14.70%
-177.47M
-81.65%
84.44M
109.22%
13.48M
114.93%
20.49M
-34.05%
-154.72M
598.02%
460.05M
-24.13%
-146.27M
-443.28%
-137.22M
-438.18%
-115.42M
-191.68%
-92.38M
-56.05%
-117.84M
63.22%
-25.26M
68.85%
-21.45M
-150.49%
-31.67M
-23.10%
-75.52M
-184.72%
-68.67M
-132.51%
-68.85M
-76.23%
62.73M
-57.62%
-61.35M
-122.28%
-24.12M
投资净额
-69.10%
43.68M
-112.82%
-894.28M
-130.87%
-23.74M
132.58%
72.62M
1934.68%
141.39M
-56.25%
-420.21M
18.62%
76.91M
-830.68%
-222.92M
170.16%
6.95M
-645.70%
-268.94M
180.35%
64.84M
-16.29%
30.51M
-116.16%
-9.90M
48.30%
-36.06M
-141.71%
-80.69M
130.82%
36.45M
413.59%
61.28M
-104.86%
-69.75M
-210.70%
-33.38M
-79.45%
-118.25M
融资净额
98.95%
-449.00K
761.33%
795.72M
-171.48%
-14.75M
-99.06%
3.67M
-184.70%
-42.68M
-78.55%
92.38M
7628.09%
20.63M
255879.61%
389.09M
2691.52%
50.39M
82741.73%
430.78M
-99.89%
267.00K
-82.22%
152.00K
-97.02%
1.81M
-71.83%
520.00K
13193.16%
250.58M
4.91%
855.00K
2099.64%
60.60M
-29.89%
1.85M
-63.05%
1.89M
-18.86%
815.00K
常见问题
Arrowhead Pharmaceuticals Inc的总收入是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,总收入达到了829.45M(同比变化3.55M)。
Arrowhead Pharmaceuticals Inc的流动资产是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,流动资产为950.64M(同比变化36.69)。
Arrowhead Pharmaceuticals Inc的总资产是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,Arrowhead Pharmaceuticals Inc的总资产为1.39B(同比变化21.54)。
Arrowhead Pharmaceuticals Inc的总负债是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,Arrowhead Pharmaceuticals Inc的总负债为881.88M(同比变化-7.05)。
Arrowhead Pharmaceuticals Inc的总权益是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,Arrowhead Pharmaceuticals Inc的总权益为503.42M(同比变化163.48)。
Arrowhead Pharmaceuticals Inc的净营业收入是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,Arrowhead Pharmaceuticals Inc的净营业收入为98.35M(同比变化116.36)。
Arrowhead Pharmaceuticals Inc的净投资是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,Arrowhead Pharmaceuticals Inc的净投资为-129.29M(同比变化69.22)。
Arrowhead Pharmaceuticals Inc的净融资是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,Arrowhead Pharmaceuticals Inc的净融资为74.01M(同比变化-91.50)。
Arrowhead Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-0.01(同比变化99.76)。
Arrowhead Pharmaceuticals Inc的净利润是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,净利润为-1.63M(同比变化99.73)。
Arrowhead Pharmaceuticals Inc的净利润率是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,净利润率为3.63(同比变化100.02)。
Arrowhead Pharmaceuticals Inc的债务与资产比率是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,债务与资产比率为44.92(同比变化-30.30)。
Arrowhead Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-0.50(同比变化99.81)。
Arrowhead Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为2.39(同比变化103.73)。
Arrowhead Pharmaceuticals Inc的营业利润是多少?
根据Arrowhead Pharmaceuticals Inc的FY2025财报,营业利润为98.35M(同比变化116.36)。